Tissue and organ damage or functional failure is a major problem faced by human medicine. Clinical treatment usually adopts surgical repair, tissue organ transplantation, artificial prosthesis implantation, mechanical device, and other schemes. To allow patients to rebuild, restore or compensate for lost functions to varying degrees. Although artificial organs and transplants have benefited many patients,
But it also revealed its fatal weakness: the former is incompatible with the human body and cannot establish advanced human functions; the latter has limited donors and has problems such as immune rejection.
With the progress of cell biology, molecular biology, bioengineering, and materials science, "tissue engineering" was born in the late 1980s and early 1990s, which opened up a new path for the rise of regenerative medicine.
Tissue engineering is the application of the principles and methods of engineering, life science, and materials science. The function-related living cells cultured and expanded in vitro are planted on porous scaffolds, and the cells proliferate and differentiate on the scaffolds to construct biological substitutes. It is then transplanted into the damaged tissue to achieve a science of repairing, maintaining, or improving the function of damaged tissue.
Tissue engineering involves growing new tissues in the laboratory, incorporating skeletons, natural tissue cells, and bioactive molecules to mimic the body's biological processes.
The tissue cytoskeleton has similar functions to the native cellular extracellular matrix (ECM). It provides the structural and material environment for cell growth, migration and response to signals, mechanical properties for the resulting tissue, and bioactive cues for the regulation of activity of resident cells.
There are three main strategies for tissue scaffolds that mimic native ECM function:
The core of tissue engineering is to build three-dimensional complexes composed of cells and biomaterials. Compared with traditional two-dimensional structures (such as cell culture), its biggest advantages are as follows:
Although tissue engineering research has only experienced a short development process of more than 30 years, it has completed a large number of basic theories, tissue construction, and implantation in animals. With the rapid development of cytology, molecular biology, and biomaterial research, great progress has been made in the research and application of tissue engineering in various tissues.
At present, commercialized tissue-engineered skin, cartilage, and other products have officially entered clinical application, and clinical applications of tissue-engineered bone, tendon, skeletal muscle, cornea, mucous membrane, and blood vessel, bladder, pancreas, genitals, kidney, liver, etc. A certain curative effect has been achieved, and tissue engineering technology, as an emerging biological high-tech technology, has broad application prospects.